Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
SIRO's Cash to Debt is ranked higher than
97% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. SIRO: No Debt )
Ranked among companies with meaningful Cash to Debt only.
SIRO' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 1.00 Max: No Debt
Current: No Debt
Equity to Asset 0.73
SIRO's Equity to Asset is ranked higher than
68% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. SIRO: 0.73 )
Ranked among companies with meaningful Equity to Asset only.
SIRO' s Equity to Asset Range Over the Past 10 Years
Min: -0.11  Med: 0.54 Max: 0.88
Current: 0.73
-0.11
0.88
Interest Coverage 34.50
SIRO's Interest Coverage is ranked higher than
59% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.08 vs. SIRO: 34.50 )
Ranked among companies with meaningful Interest Coverage only.
SIRO' s Interest Coverage Range Over the Past 10 Years
Min: 1.68  Med: 40.92 Max: 9999.99
Current: 34.5
1.68
9999.99
F-Score: 6
Z-Score: 9.45
M-Score: -2.50
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 22.36
SIRO's Operating margin (%) is ranked higher than
88% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. SIRO: 22.36 )
Ranked among companies with meaningful Operating margin (%) only.
SIRO' s Operating margin (%) Range Over the Past 10 Years
Min: 8.16  Med: 18.29 Max: 35.64
Current: 22.36
8.16
35.64
Net-margin (%) 16.33
SIRO's Net-margin (%) is ranked higher than
87% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.00 vs. SIRO: 16.33 )
Ranked among companies with meaningful Net-margin (%) only.
SIRO' s Net-margin (%) Range Over the Past 10 Years
Min: 3.89  Med: 13.33 Max: 22.45
Current: 16.33
3.89
22.45
ROE (%) 14.82
SIRO's ROE (%) is ranked higher than
82% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.62 vs. SIRO: 14.82 )
Ranked among companies with meaningful ROE (%) only.
SIRO' s ROE (%) Range Over the Past 10 Years
Min: 4.64  Med: 13.98 Max: 26.05
Current: 14.82
4.64
26.05
ROA (%) 10.50
SIRO's ROA (%) is ranked higher than
84% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.92 vs. SIRO: 10.50 )
Ranked among companies with meaningful ROA (%) only.
SIRO' s ROA (%) Range Over the Past 10 Years
Min: 1.78  Med: 7.83 Max: 22.72
Current: 10.5
1.78
22.72
ROC (Joel Greenblatt) (%) 85.40
SIRO's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.41 vs. SIRO: 85.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SIRO' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 45.65  Med: 86.54 Max: 275.82
Current: 85.4
45.65
275.82
Revenue Growth (3Y)(%) 6.10
SIRO's Revenue Growth (3Y)(%) is ranked higher than
58% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. SIRO: 6.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SIRO' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -23.4  Med: 9.30 Max: 72
Current: 6.1
-23.4
72
EBITDA Growth (3Y)(%) 7.00
SIRO's EBITDA Growth (3Y)(%) is ranked higher than
50% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.30 vs. SIRO: 7.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SIRO' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -29  Med: 12.40 Max: 81.4
Current: 7
-29
81.4
EPS Growth (3Y)(%) 11.90
SIRO's EPS Growth (3Y)(%) is ranked higher than
65% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.60 vs. SIRO: 11.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SIRO' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -8.7  Med: 13.70 Max: 58.7
Current: 11.9
-8.7
58.7
» SIRO's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-07)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

SIRO Guru Trades in Q2 2015

Joel Greenblatt 8,577 sh (New)
Columbia Wanger 611,440 sh (+6.29%)
Ruane Cunniff 2,841,520 sh (+0.51%)
Ron Baron 63,252 sh (-6.16%)
Jeremy Grantham 48,900 sh (-24.54%)
» More
Q3 2015

SIRO Guru Trades in Q3 2015

Paul Tudor Jones 3,600 sh (New)
Ron Baron Sold Out
Joel Greenblatt Sold Out
Ruane Cunniff 2,826,405 sh (-0.53%)
Columbia Wanger 585,014 sh (-4.32%)
Jeremy Grantham 45,975 sh (-5.98%)
» More
Q4 2015

SIRO Guru Trades in Q4 2015

Jim Simons 241,600 sh (New)
Andreas Halvorsen 34,671 sh (New)
Paul Tudor Jones Sold Out
Ruane Cunniff 2,789,596 sh (-1.30%)
Jeremy Grantham 42,775 sh (-6.96%)
Columbia Wanger 454,184 sh (-22.36%)
» More
Q1 2016

SIRO Guru Trades in Q1 2016

Andreas Halvorsen Sold Out
Jim Simons Sold Out
Jeremy Grantham Sold Out
Columbia Wanger Sold Out
Ruane Cunniff Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SIRO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:OTCPK:SAUHY, NYSE:STE, NYSE:WST, OTCPK:GNGBY, NYSE:COO, NYSE:HRC, NYSE:RMD, NYSE:CMN, OTCPK:ANSLF, NAS:HOLX, OTCPK:AMFPF, NAS:PODD, NYSE:MTD, NAS:ICUI, NYSE:HYH, NYSE:HAE, NAS:NXTM, NAS:ELGX, NYSE:GKOS, OTCPK:TOPCF » details
Traded in other countries:RXT.Germany,
Sirona Dental Systems Inc is a manufacturer of dental equipments. The Company is engaged in developing, manufacturing, and marketing solutions for dentists around the world.

Sirona Dental Systems Inc was founded in 1997 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, dental equipment, and is engaged in developing, manufacturing and marketing solutions for dentists around the world. The Company provides products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 480 distributors. The Companys registered trademarks include, Sirona, CEREC, Orthophos, Heliodent, inLab, CDR, and Schick. It competes with different companies which include international companies as well as smaller companies that compete regionally or on a narrower product line. The Company is subject to government regulations applicable to all businesses

Ratios

vs
industry
vs
history
P/E(ttm) 32.44
SIRO's P/E(ttm) is ranked lower than
63% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.89 vs. SIRO: 32.44 )
Ranked among companies with meaningful P/E(ttm) only.
SIRO' s P/E(ttm) Range Over the Past 10 Years
Min: 15.83  Med: 27.31 Max: 766.86
Current: 32.44
15.83
766.86
Forward P/E 24.39
SIRO's Forward P/E is ranked lower than
61% of the 41 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.32 vs. SIRO: 24.39 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 32.44
SIRO's PE(NRI) is ranked lower than
63% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.89 vs. SIRO: 32.44 )
Ranked among companies with meaningful PE(NRI) only.
SIRO' s PE(NRI) Range Over the Past 10 Years
Min: 15.82  Med: 27.24 Max: 782.2
Current: 32.44
15.82
782.2
Price/Owner Earnings (ttm) 39.70
SIRO's Price/Owner Earnings (ttm) is ranked lower than
66% of the 76 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.98 vs. SIRO: 39.70 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
SIRO' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 8.67  Med: 23.92 Max: 179.4
Current: 39.7
8.67
179.4
P/B 4.51
SIRO's P/B is ranked lower than
65% of the 207 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. SIRO: 4.51 )
Ranked among companies with meaningful P/B only.
SIRO' s P/B Range Over the Past 10 Years
Min: 0.84  Med: 3.21 Max: 11.62
Current: 4.51
0.84
11.62
P/S 5.29
SIRO's P/S is ranked lower than
72% of the 212 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. SIRO: 5.29 )
Ranked among companies with meaningful P/S only.
SIRO' s P/S Range Over the Past 10 Years
Min: 0.74  Med: 3.36 Max: 7.44
Current: 5.29
0.74
7.44
PFCF 32.20
SIRO's PFCF is ranked lower than
64% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.29 vs. SIRO: 32.20 )
Ranked among companies with meaningful PFCF only.
SIRO' s PFCF Range Over the Past 10 Years
Min: 9.64  Med: 22.94 Max: 101.08
Current: 32.2
9.64
101.08
POCF 25.38
SIRO's POCF is ranked lower than
77% of the 103 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.88 vs. SIRO: 25.38 )
Ranked among companies with meaningful POCF only.
SIRO' s POCF Range Over the Past 10 Years
Min: 5.91  Med: 16.30 Max: 112.73
Current: 25.38
5.91
112.73
EV-to-EBIT 22.56
SIRO's EV-to-EBIT is ranked lower than
58% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.84 vs. SIRO: 22.56 )
Ranked among companies with meaningful EV-to-EBIT only.
SIRO' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.5  Med: 19.50 Max: 97.1
Current: 22.56
10.5
97.1
EV-to-EBITDA 17.78
SIRO's EV-to-EBITDA is ranked lower than
53% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.39 vs. SIRO: 17.78 )
Ranked among companies with meaningful EV-to-EBITDA only.
SIRO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 12.90 Max: 57.5
Current: 17.78
5.5
57.5
PEG 3.68
SIRO's PEG is ranked lower than
61% of the 61 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. SIRO: 3.68 )
Ranked among companies with meaningful PEG only.
SIRO' s PEG Range Over the Past 10 Years
Min: 0.38  Med: 1.98 Max: 19.34
Current: 3.68
0.38
19.34
Shiller P/E 57.26
SIRO's Shiller P/E is ranked lower than
75% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.46 vs. SIRO: 57.26 )
Ranked among companies with meaningful Shiller P/E only.
SIRO' s Shiller P/E Range Over the Past 10 Years
Min: 31.32  Med: 49.84 Max: 60.07
Current: 57.26
31.32
60.07
Current Ratio 2.89
SIRO's Current Ratio is ranked higher than
56% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.51 vs. SIRO: 2.89 )
Ranked among companies with meaningful Current Ratio only.
SIRO' s Current Ratio Range Over the Past 10 Years
Min: 0.75  Med: 2.20 Max: 8.27
Current: 2.89
0.75
8.27
Quick Ratio 2.45
SIRO's Quick Ratio is ranked higher than
66% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. SIRO: 2.45 )
Ranked among companies with meaningful Quick Ratio only.
SIRO' s Quick Ratio Range Over the Past 10 Years
Min: 0.17  Med: 1.73 Max: 7.7
Current: 2.45
0.17
7.7
Days Inventory 91.89
SIRO's Days Inventory is ranked higher than
72% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.38 vs. SIRO: 91.89 )
Ranked among companies with meaningful Days Inventory only.
SIRO' s Days Inventory Range Over the Past 10 Years
Min: 41.2  Med: 71.95 Max: 89.92
Current: 91.89
41.2
89.92
Days Sales Outstanding 60.05
SIRO's Days Sales Outstanding is ranked higher than
52% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.94 vs. SIRO: 60.05 )
Ranked among companies with meaningful Days Sales Outstanding only.
SIRO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.03  Med: 46.59 Max: 50.29
Current: 60.05
36.03
50.29
Days Payable 34.99
SIRO's Days Payable is ranked lower than
71% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.12 vs. SIRO: 34.99 )
Ranked among companies with meaningful Days Payable only.
SIRO' s Days Payable Range Over the Past 10 Years
Min: 35.31  Med: 41.84 Max: 52.38
Current: 34.99
35.31
52.38

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 16.79
SIRO's Price/Net Current Asset Value is ranked lower than
76% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.62 vs. SIRO: 16.79 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SIRO' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 4  Med: 8.81 Max: 3510
Current: 16.79
4
3510
Price/Tangible Book 10.53
SIRO's Price/Tangible Book is ranked lower than
85% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.52 vs. SIRO: 10.53 )
Ranked among companies with meaningful Price/Tangible Book only.
SIRO' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.01  Med: 9.74 Max: 195.23
Current: 10.53
1.01
195.23
Price/Projected FCF 2.10
SIRO's Price/Projected FCF is ranked lower than
56% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.91 vs. SIRO: 2.10 )
Ranked among companies with meaningful Price/Projected FCF only.
SIRO' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.53  Med: 1.57 Max: 12.81
Current: 2.1
0.53
12.81
Price/DCF (Earnings Based) 1.19
SIRO's Price/DCF (Earnings Based) is ranked higher than
72% of the 18 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.91 vs. SIRO: 1.19 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.57
SIRO's Price/Median PS Value is ranked lower than
79% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. SIRO: 1.57 )
Ranked among companies with meaningful Price/Median PS Value only.
SIRO' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.03  Med: 0.89 Max: 2.21
Current: 1.57
0.03
2.21
Price/Peter Lynch Fair Value 3.93
SIRO's Price/Peter Lynch Fair Value is ranked lower than
67% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. SIRO: 3.93 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SIRO' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.48  Med: 2.00 Max: 30.26
Current: 3.93
0.48
30.26
Price/Graham Number 3.90
SIRO's Price/Graham Number is ranked lower than
72% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. SIRO: 3.90 )
Ranked among companies with meaningful Price/Graham Number only.
SIRO' s Price/Graham Number Range Over the Past 10 Years
Min: 0.86  Med: 3.50 Max: 14.68
Current: 3.9
0.86
14.68
Earnings Yield (Greenblatt) (%) 4.40
SIRO's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.33 vs. SIRO: 4.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SIRO' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1  Med: 5.10 Max: 9.5
Current: 4.4
1
9.5
Forward Rate of Return (Yacktman) (%) 10.63
SIRO's Forward Rate of Return (Yacktman) (%) is ranked higher than
62% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.73 vs. SIRO: 10.63 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SIRO' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 2  Med: 22.10 Max: 56.1
Current: 10.63
2
56.1

More Statistics

Revenue (TTM) (Mil) $1,173
EPS (TTM) $ 3.39
Short Percentage of Float2.73%
52-Week Range $86.29 - 113.58
Shares Outstanding (Mil)56.03

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 163
Sep16
Revenue (Mil $)
EPS ($) 4.51
EPS w/o NRI ($) 4.51
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NAS:SIRO

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CEO Buys Highlight: KMI, VGR, SIRO, PNK, MASI Nov 27 2011 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Nov 18 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Feb 23 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Dec 17 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Dec 04 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Jul 31 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) May 06 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Feb 05 2009 

More From Other Websites
Thirty-three users from 18 countries: International summit for Dentsply Sirona ... Jun 08 2016
Successful Launch of the Dentsply Sirona CAD/CAM Disc Line Mar 24 2016
Dentsply Sirona Instruments Introduces Online Knowledge Sharing Platform for ... Mar 22 2016
DENTSPLY & Sirona Dental Systems Unite, Form New Entity Mar 01 2016
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Feb 29 2016
PrivateBancorp Set to Join the S&P MidCap 400; Cogent Communications to Join S&P SmallCap 600 Feb 26 2016
Dentsply wins conditional EU approval for $5.6 bln Sirona bid Feb 25 2016
DENTSPLY and Sirona Announce Completion of Remaining Regulatory Milestones for Proposed Merger Feb 25 2016
SIRONA DENTAL SYSTEMS, INC. Financials Feb 11 2016
Sirona Dental Systems, Inc. Earnings Analysis: Q1, 2016 By the Numbers Feb 10 2016
Sirona Dental tops Street 1Q forecasts Feb 08 2016
Sirona Dental tops Street 1Q forecasts Feb 08 2016
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 08 2016
SIRONA DENTAL SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report Feb 08 2016
Sirona Reports Fiscal 2016 First Quarter Results Feb 08 2016
Sirona Dental Systems, Inc. breached its 50 day moving average in a Bullish Manner : February 2,... Feb 02 2016
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jan 11 2016
DENTSPLY AND SIRONA SHAREHOLDERS APPROVE MERGER Jan 11 2016
DENTSPLY AND SIRONA SHAREHOLDERS APPROVE MERGER Jan 11 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)